Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Olsson-Brown AC"'
Autor:
Várnai, C, Palles, C, Arnold, R, Curley, HM, Purshouse, K, Cheng, VWT, Booth, S, Campton, NA, Collins, GP, Hughes, DJ, Kulasekararaj, AG, Lee, AJX, Olsson-Brown, AC, Sharma-Oates, A, Van Hemelrijck, M, Lee, LYW, Kerr, R, Middleton, G, Cazier, J-B, UKCCMP Team
Importance Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence of the association of recent cancer treatment and cancer type with COVID-19 mortality. Objective To evaluate whether systemic anticancer tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3ff0a2c1612604ec79d5d24fc67d34d0
https://eprints.whiterose.ac.uk/184087/1/vrnai_2022_oi_220011_1644548912.0317.pdf
https://eprints.whiterose.ac.uk/184087/1/vrnai_2022_oi_220011_1644548912.0317.pdf
Autor:
Lee, LY, Cazier, J-B, Angelis, V, Arnold, R, Bisht, V, Campton, NA, Chackathayil, J, Cheng, VW, Curley, HM, Fittall, MW, Freeman-Mills, L, Gennatas, S, Goel, A, Hartley, S, Hughes, DJ, Kerr, D, Lee, AJ, Lee, RJ, McGrath, SE, Middleton, CP, Murugaesu, N, Newsom-Davis, T, Okines, AF, Olsson-Brown, AC, Palles, C, Pan, Y, Pettengell, R, Powles, T, Protheroe, EA, Purshouse, K, Sharma-Oates, A, Sivakumar, S, Smith, AJ, Starkey, T, Turnbull, CD, Várnai, C, Yousaf, N, Team, UK Coronavirus Monitoring Project, Kerr, R, Middleton, G
Publikováno v:
The Lancet
Purshouse, K 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments : a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
The UK Coronavirus Monitoring Project Team 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
Purshouse, K 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments : a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
The UK Coronavirus Monitoring Project Team 2020, ' COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study ', The Lancet, vol. 395, no. 10241, pp. 1919-1926 . https://doi.org/10.1016/S0140-6736(20)31173-9
Background Individuals with cancer, particularly those who are receiving systemic anticancer treatments, have been postulated to be at increased risk of mortality from COVID-19. This conjecture has considerable effect on the treatment of patients wit
Autor:
Kalakonda AJM; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.; CRN North West Coast, NIHR, Liverpool, UK., Mahajan A; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Chow S; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Olsson-Brown AC; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.; University of Liverpool, Liverpool, UK., Sacco JJ; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.; University of Liverpool, Liverpool, UK.
Publikováno v:
Case reports in oncology [Case Rep Oncol] 2024 Mar 27; Vol. 17 (1), pp. 497-503. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Autor:
Várnai C; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Cancer Research UK Birmingham Centre, University of Birmingham, United Kingdom., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, United Kingdom., Cheng VWT; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom., Booth S; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, United Kingdom., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, United Kingdom., Collins GP; Oxford NIHR Biomedical Research Centre, Department of Haematology, Churchill Hospital, Oxford, United Kingdom., Hughes DJ; Department of Cancer Imaging, King's College London, London, United Kingdom., Kulasekararaj AG; Department of Haematology, King's College Hospital, London, United Kingdom., Lee AJX; UCL Cancer Institute, University College London, London, United Kingdom., Olsson-Brown AC; The Clatterbridge Cancer Centre, Wirral, United Kingdom.; The University of Liverpool, Liverpool, United Kingdom., Sharma-Oates A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Oncology, Oxford University, Oxford, United Kingdom., Kerr R; Department of Oncology, Oxford University, Oxford, United Kingdom., Middleton G; Cancer Research UK Birmingham Centre, University of Birmingham, United Kingdom.; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, United Kingdom.; Queen Elizabeth Hospital, Birmingham, United Kingdom., Cazier JB; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Cancer Research UK Birmingham Centre, University of Birmingham, United Kingdom.; Queen Elizabeth Hospital, Birmingham, United Kingdom.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e220130. Date of Electronic Publication: 2022 Feb 01.
Autor:
Dearden H; Leeds Cancer Centre, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK., Baxter MA; Division of Molecular and Clinical Medicine, University of Dundee School of Medicine, Dundee, UK m.z.baxter@dundee.ac.uk.; Tayside Cancer Centre, Ninewells Hospital, NHS Tayside, Dundee, UK., Martin S; Leeds Cancer Centre, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK., Rowe M; Plymouth Oncology Centre, Derriford Hospital Cancer Services Department, Plymouth, Plymouth, UK., Zucker K; Leeds Cancer Centre, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK., Jones CM; Leeds Cancer Centre, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK., Olsson-Brown AC; Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK., Petty RD; Division of Molecular and Clinical Medicine, University of Dundee School of Medicine, Dundee, UK.; Tayside Cancer Centre, Ninewells Hospital, NHS Tayside, Dundee, UK., Swinson D; Leeds Cancer Centre, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Sep 28; Vol. 11 (9), pp. e051104. Date of Electronic Publication: 2021 Sep 28.
Autor:
Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Oncology, University of Oxford, Oxford, UK; University Hospitals Birmingham, Birmingham, UK., Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Briggs SEW; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Bisht V; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Booth S; Department of Haematology, University of Oxford, Oxford, UK., Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK., Cheng VWT; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Collins G; Department of Haematology, University of Oxford, Oxford, UK., Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Earwaker P; University Hospitals Birmingham, Birmingham, UK., Fittall MW; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Gennatas S; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Goel A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Hartley S; Centre for Computational Biology, University of Birmingham, Birmingham, UK; Advanced Research Computing, University of Birmingham, Birmingham, UK., Hughes DJ; Department of Cancer Imaging, King's College London, London, UK., Kerr D; Nuffield Division of Clinical and Laboratory Services, University of Oxford, Oxford, UK., Lee AJX; UCL Cancer Institute, University College London, London, UK., Lee RJ; The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Lee SM; University College London, London, UK., Mckenzie H; University Hospital Southampton, UK., Middleton CP; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Murugaesu N; St George's University Hospitals NHS Foundation Trust, London, UK., Newsom-Davis T; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Olsson-Brown AC; The Clatterbridge Cancer Centre, Birkenhead, UK., Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Powles T; Bart's Cancer Institute, London, UK., Protheroe EA; University of Birmingham Medical School, University of Birmingham, Birmingham, UK., Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK., Sharma-Oates A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Sivakumar S; Department of Oncology, University of Oxford, Oxford, UK., Smith AJ; Consultancy Support, Oxford, UK., Topping O; University Hospitals Birmingham, Birmingham, UK., Turnbull CD; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Várnai C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK., Briggs ADM; Warwick Medical School, University of Warwick, Coventry, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK. Electronic address: g.middleton@bham.ac.uk., Kerr R; Department of Oncology, University of Oxford, Oxford, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Oct; Vol. 21 (10), pp. 1309-1316. Date of Electronic Publication: 2020 Aug 24.